Navigation Links
Avitar Reports Fourth Quarter and Fiscal Year 2007 Financial Results
Date:12/28/2007

for the Hydrasorb(R) wound dressing products, increases in interest and financing costs of $109,000 related to the long-term debt borrowings undertaken during fiscal 2007, a reduction in non-cash income of $360,000 resulting from changes in fair market value of derivative securities and warrants, offset in part by lower operating expenses of $696,000 resulting from the reduced sales volume and an expense reduction program implemented in April 2007 and a decrease in the loss from discontinued operations of $194,000.

Peter P. Phildius, Chairman and CEO commented, "Despite our capital constraints we continue our efforts to grow the Company. As previously reported, we are positioning our oral fluid, drugs of abuse product line, Oralscreen, to address the needs of larger employers across several industry sectors. Particularly in the construction vertical market where the incidence of drug abuse has reached as high as 20%, we are beginning to see traction from our sales and marketing efforts."

Mr. Phildius continued, "As we have previously noted, our foam business continues to be negatively impacted by the lack of sales by the new distributor of our Hydrasorb product line. We are working to develop new distribution channels for Hydrasorb and, in addition, we are expanding our customer base in the foam product area to reduce our dependence in the future on our branded Hydrasorb product line."

ABOUT AVITAR

Avitar, Inc. develops, manufactures and markets innovative and proprietary products in the oral fluid diagnostic market, disease and clinical testing market, and customized polyurethane applications used in the wound dressing industry. Oral fluid diagnostics includes the estimated $1.5 billion drugs-of- abuse testing market, which encompasses the corporate workplace and criminal justice markets. Avitar's products include ORALscreen(TM), the world's first non-invasive, rapid, onsite oral fluid test for drugs-of-abuse. Additionally, Avitar manuf
'/>"/>

SOURCE Avitar, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Avitars Notes Significance of New On-Site Oral Fluid Drug Testing Laws
2. Avitar Reports Third Quarter Financial Results for Fiscal 2007
3. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
4. QMed, Inc. Reports July Medicare SNP Enrollments
5. Phlo Affiliate Reports Expanded Coverage to Oregon Border
6. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
7. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
8. Carrington Reports Second Quarter 2007 Results
9. Response Genetics Reports Second Quarter 2007 Financial Results
10. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
11. Transgenomic, Inc. Reports Second Quarter 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... , 23 de julio de 2014 /PRNewswire/ ... o la Compañía) ha anunciado hoy una asociación ... (ABIA o el Instituto), para el ... un dispositivo de terapia de señal bioeléctrica (el ... El Instituto, que tiene una importante experiencia ...
(Date:7/23/2014)... , July 23, 2014 /PRNewswire/ - BioAmber Inc. ... company producing sustainable chemicals, today announced that the underwriters ... their option to purchase an additional 420,000 shares ... of $12.00 per share, less underwriting discounts and ... public offering of 2,800,000 shares of common stock, ...
(Date:7/23/2014)... July 23, 2014  Sofinnova Ventures, a ... the closing of Sofinnova Venture Partners IX, L.P. at ... of the initial fund target of $425 million. ... biotechnology companies. Consistent with recent funds, SVP IX will ... clinical programs, along with select investments in earlier stage ...
(Date:7/23/2014)... Columbia, MD (PRWEB) July 23, 2014 ... Booth and ChirpE Mobile App, AACC Pathfinder, in its ... event offerings. AACC’s annual meeting is planned for July ... is the place to be to connect with global ... medicine, lab management, and other areas of breaking science ...
Breaking Biology Technology:ADB International Group Inc. anuncia una asociación con Austen BioInnovation Institute 2ADB International Group Inc. anuncia una asociación con Austen BioInnovation Institute 3ADB International Group Inc. anuncia una asociación con Austen BioInnovation Institute 4ADB International Group Inc. anuncia una asociación con Austen BioInnovation Institute 5ADB International Group Inc. anuncia una asociación con Austen BioInnovation Institute 6BioAmber announces exercise in full of underwriters' option in connection with previously priced follow-on offering 2BioAmber announces exercise in full of underwriters' option in connection with previously priced follow-on offering 3Sofinnova Raises $500 Million Biotech Venture Fund 2AACC Enhances Attendee Experience at Its 2014 Annual Meeting & Clinical Lab Expo with a2z-Powered ChirpE Photo Booth and Mobile App 2AACC Enhances Attendee Experience at Its 2014 Annual Meeting & Clinical Lab Expo with a2z-Powered ChirpE Photo Booth and Mobile App 3
... Australia, July 16 Dow AgroSciences LLC, a wholly owned subsidiary ... NemGenix, a Perth based biotechnology company, announced today a newly established ... , , The collaboration will support ... terms of the agreement were not disclosed. , ...
... , , , ... (OTC Bulletin Board: CSBR), a company engaged in ... to enhance the value of oncology drugs, has established a ... a more soluble form of SG410, its Benzoylphenylurea (BPU) sulfur ...
... TAIAN CITY, China, July 16 /PRNewswire-Asia-FirstCall/ ... Biologic" or the "Company"),one of the leading plasma-based pharmaceutical ... that the Company hosted a forum of,industry experts on ... Tai,an,Shandong Province, to discuss future development strategies for the ...
Cached Biology Technology:Dow AgroSciences, NemGenix Establish New Collaboration in Plant Biotechnology 2Champions Biotechnology Partners with Do-Coop Technologies to Advance Its Novel Oncology Compound Into Biomerk Tumorgraft(TM) Testing 2Champions Biotechnology Partners with Do-Coop Technologies to Advance Its Novel Oncology Compound Into Biomerk Tumorgraft(TM) Testing 3Champions Biotechnology Partners with Do-Coop Technologies to Advance Its Novel Oncology Compound Into Biomerk Tumorgraft(TM) Testing 4China Biologic Products Hosts its First Forum for Strategy and Development 2China Biologic Products Hosts its First Forum for Strategy and Development 3
(Date:7/23/2014)... the movements of satellite-tagged blue whales off the West ... feeding areas are bisected by heavily used shipping lanes, ... researchers note that moving the shipping lanes off Los ... at least, during summer and fall when blue whales ... of ships striking the whales. A similar relocation of ...
(Date:7/23/2014)... songbirds are disappearing, and though conservationists are examining several ... acid rain and light pollution, a key piece of ... go once they leave their breeding sites, and what ... To answer this question, a team of researchers out ... connectivity map produced for a songbird, using tracking from ...
(Date:7/23/2014)... Non-biting blow fly Chrysomya megacephala is commonly ... investigations to determine the time of death, referred to ... derived form of C. megacephala from Tamil ... morphological features and molecular characterization through generation of DNA ... in the open access Biodiversity Data Journal . ...
Breaking Biology News(10 mins):15-year analysis of blue whale range off California finds conflict with shipping lanes 215-year analysis of blue whale range off California finds conflict with shipping lanes 315-year analysis of blue whale range off California finds conflict with shipping lanes 4York University researchers use bird 'backpacks' to put wood thrushes migration on the map 2Dead body feeding larvae useful in forensic investigations 2
... a remarkably primitive eel in a fringing reef off the ... primitive anatomical features unknown in the other 19 families and ... classification as a new species belonging to a new genus ... Proceedings of the Royal Society B , Aug. 17. ...
... CHICAGO- Acai berry, cumin, herbal tea, turmeric and long-term ... to be beneficial to your health may negatively ... at the American Society of Clinical Oncology (ASCO) meeting ... hospital say there is growing evidence that these popular ...
... at UCLA have discovered that three types of cells derived ... are similar to each other, but are much more developmentally ... types taken directly from human tissue. The researchers, from ... Stem Cell Research at UCLA, found that the progeny of ...
Cached Biology News:Scientists discover the most primitive living eel 2Popular herbal supplements may adversely affect chemotherapy treatment 2Popular herbal supplements may adversely affect chemotherapy treatment 3Cells derived from pluripotent stem cells are developmentally immature 2Cells derived from pluripotent stem cells are developmentally immature 3
... The desk-top XCAT 50 X-Ray System from ... ability to provide two and three dimensional representation ... series provides volumetric reconstruction of specimen X-ray images, ... to provide high level of detail in standard ...
... in which a lack of balance exists ... antioxidants. Oxidative stress appears to be ... including artherosclerosis, chronic inflammatory diseases, and cancer. ... that are very important for the prevention ...
... Sets contain the basic components and ... sandwich ELISA plates for quantitation of ... of cell culture supernate. Every Screening ... Recombinant Standard (5 individual standards), Streptavidin-HRP, ...
... revolutionizes DNA sequencing, delivering sequence data in ... Sequencer 20 System includes: Instrument ... library construction, amplification, and sequencing Analysis ... The instrument is the ...
Biology Products: